Compare SLBT & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLBT | SMWB |
|---|---|---|
| Founded | N/A | 2007 |
| Country | Taiwan | Israel |
| Employees | N/A | N/A |
| Industry | | Computer Software: Programming Data Processing |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.1M | 778.8M |
| IPO Year | 2025 | 2021 |
| Metric | SLBT | SMWB |
|---|---|---|
| Price | $1.66 | $8.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $10.83 |
| AVG Volume (30 Days) | 108.5K | ★ 511.1K |
| Earning Date | N/A | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | N/A | $11.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $2.22 |
| 52 Week High | $6.25 | $9.52 |
| Indicator | SLBT | SMWB |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 47.33 |
| Support Level | N/A | $7.83 |
| Resistance Level | $3.36 | $9.03 |
| Average True Range (ATR) | 0.18 | 0.44 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 32.89 | 41.67 |
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.